Evidence map›Paper›PMID 25126393›Full record

ReviewWorld journal of diabetes2014

Structured SMBG in early management of T2DM: Contributions from the St Carlos study.

Teresa Ruiz Gracia, Nuria García de la Torre Lobo, Alejandra Durán Rodríguez Hervada, Alfonso L Calle Pascual

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Teresa Ruiz GraciaTeresa Ruiz Gracia, Nuria García de la Torre Lobo, Alejandra Durán Rodríguez Hervada, Alfonso L Calle Pascual, Department of Endocrinology and Nutrition, Hospital Clínico San Carlos, Universidad Complutense, 28040 Madrid, Spain.
Nuria García de la Torre LoboTeresa Ruiz Gracia, Nuria García de la Torre Lobo, Alejandra Durán Rodríguez Hervada, Alfonso L Calle Pascual, Department of Endocrinology and Nutrition, Hospital Clínico San Carlos, Universidad Complutense, 28040 Madrid, Spain.
Alejandra Durán Rodríguez HervadaTeresa Ruiz Gracia, Nuria García de la Torre Lobo, Alejandra Durán Rodríguez Hervada, Alfonso L Calle Pascual, Department of Endocrinology and Nutrition, Hospital Clínico San Carlos, Universidad Complutense, 28040 Madrid, Spain.
Alfonso L Calle PascualTeresa Ruiz Gracia, Nuria García de la Torre Lobo, Alejandra Durán Rodríguez Hervada, Alfonso L Calle Pascual, Department of Endocrinology and Nutrition, Hospital Clínico San Carlos, Universidad Complutense, 28040 Madrid, Spain.
Creative Research Enterprises (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus type 2 (T2DM) is a global pandemic that will affect 300 million people in the next decade. It has been shown that early and aggressive treatment of T2DM from the onset decreases complications, and the patient's active role is necessary to achieve better glycemic control. In order to achieve glycemic control targets, an active attitude in patients is needed, and self-monitoring of blood glucose (SMBG) plays a significant role. Nowadays, SMBG has become an important component of modern therapy for diabetes mellitus, and is even more useful if it is performed in a structured way. SMBG aids physicians and patients to achieve a specific level of glycemic control and to prevent hypoglycemia. In addition, SMBG empowers patients to achieve nutritional and physical activity goals, and helps physicians to optimize the different hypoglycemic therapies as demonstrated in the St Carlos study. This article describes the different ways of using this educational and therapeutic tool from the medical point of view as well as from the patient's perspective.

Indexed as

Diabetes mellitus type 2EducationalManagementStructured self-monitoring of blood glucoseTherapeuticTool

Identifiers

PMID25126393
PMCPMC4127582
OpenAlexW2329174205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.